OneMedNet Corp SEC filings ONMD
OneMedNet Corp has 289 filings in SEC EDGAR's recent list, going back to Mar 9, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 10, 2026 | — |
| EFFECT | Filing | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| CORRESP | Letter to the SEC | Jan 31, 2025 | — |
| NT 10-Q | Filing | Nov 15, 2024 | Sep 30, 2024 |
| D | Filing | Aug 2, 2024 | — |
| NT 10-Q | Filing | May 14, 2024 | Mar 31, 2024 |
| CORRESP | Letter to the SEC | May 6, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 16, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Jan 8, 2024 | — |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| SEC STAFF LETTER | Filing | Nov 13, 2023 | — |
| 25-NSE | Delisting notice | Nov 7, 2023 | — |
| 425 | Filing | Oct 18, 2023 | — |
| 425 | Filing | Oct 17, 2023 | — |
| 425 | Filing | Oct 12, 2023 | — |
| 425 | Filing | Oct 10, 2023 | — |
| 425 | Filing | Sep 25, 2023 | — |
| EFFECT | Filing | Sep 22, 2023 | — |
| CORRESP | Letter to the SEC | Sep 21, 2023 | — |
| 425 | Filing | Sep 18, 2023 | — |
| CORRESP | Letter to the SEC | Aug 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2023 | — |
| 425 | Filing | Aug 14, 2023 | — |
| 425 | Filing | Aug 11, 2023 | — |
| PRER14A | Filing | Aug 4, 2023 | — |
| PRER14A | Filing | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Aug 1, 2023 | — |
| 425 | Filing | Jul 31, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2023 | — |
| 425 | Filing | Jul 12, 2023 | — |
| CORRESP | Letter to the SEC | Jul 3, 2023 | — |
| 425 | Filing | Jun 13, 2023 | — |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| SEC STAFF LETTER | Filing | Apr 26, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2023 | — |
| CORRESP | Letter to the SEC | Apr 10, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2023 | — |
| CORRESP | Letter to the SEC | Feb 3, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2022 | — |
| NT 10-Q | Filing | Nov 14, 2022 | Sep 30, 2022 |
| CORRESP | Letter to the SEC | Nov 10, 2022 | — |
| 425 | Filing | Nov 8, 2022 | — |
| 425 | Filing | Nov 7, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2022 | — |
| PRER14A | Filing | Oct 25, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 29, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Jul 22, 2022 | — |
| 425 | Filing | May 20, 2022 | — |
| 425 | Filing | May 12, 2022 | — |
| 425 | Filing | May 6, 2022 | — |
| 425 | Filing | Apr 25, 2022 | — |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| EFFECT | Filing | May 6, 2021 | — |
| CERT | Filing | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| 8-A12B | Form 8-a12b | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 4, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2021 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ONMD (Nasdaq), ONMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Surrey, United Kingdom
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1849380
- Former names
- Data Knights Acquisition Corp. (until Nov 7, 2023)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.